News & Events

Supreme Court Rejects Challenges to $2.67 Billion BCBS Settlement

David Boies
David Boies, Founding Partner
/
vCard
Hamish Hume
Hamish P. M. Hume, Partner
/
vCard
Adam Shaw
Adam R. Shaw, Partner
/
vCard
Alexander Boies
Alexander Boies, Partner
/
vCard
Eric Palmer
Eric M. Palmer, Partner
/
vCard

JUNE 24, 2024

Announcements

The Supreme Court denies remaining challenges to the historic $2.67 billion nationwide class action settlement against Blue Cross Blue Shield.  

On Monday, June 24, 2024, the U.S. Supreme Court denied two petitions for certiorari from the only remaining objectors to the settlement in the case In re Blue Cross Blue Shield Antitrust Litigation. These rulings mark the final stage in the court approval of the settlement. In addition to the monetary award of $2.67 billion, which is one of the largest ever monetary settlements in a private antitrust case without government involvement, the settlement also includes significant injunctive relief that should improve competition in the health insurance market.

The settlement resolves civil antitrust claims by subscribers that Blue Cross Blue Shield Association and member plans conspired to drive up health insurance costs. 

The BSF team representing the subscriber class includes David Boies, Hamish Hume, Adam Shaw, Alex Boies, and Eric Palmer. 

LAW360: Justices Won't Hear Objections To $2.67B BCBS Deal

REUTERS: US Supreme Court rejects challenge to $2.7 bln Blue Cross settlement

Related People

  • Legal
  • Privacy and Cookie Policy
  • London Legal Notices
  • Italy privacy notices/Informative privacy Italia
  • Visit Us On LinkedIn

Copyright © 2025 Boies Schiller Flexner LLP.

All Rights Reserved.

Attorney Advertising.

Prior results do not guarantee a similar outcome.

Boies Schiller Flexner

Boies Schiller Flexner

  • Search
  • Email
    • Twitter
    • Facebook
    • LinkedIn
    • Google+
  • My Binder 
    Add To Binder
  • About Us
  • Practices
  • People
  • Diversity
  • Careers
  • News & Events
  • Locations
Search
We use cookies to enhance your experience on our website. By using this site, you consent to our Cookie Policy.